IMPORTANT TOPICS IN CTO

Monday, March 10, 2025

8:00 AM - 10:28 AM ET

Moderator(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

No relationships to disclose
Carlo Di Mario, MD

Professor
University of Florence
Florence, Toscana, Italy

No relationships to disclose
Craig Thompson, MD, MMSc

Director, Interventional Cardiology Hartford Healthcare Heart and Vascular Institute
Hartford Healthcare
Hartford, Connecticut, United States

Disclosure information not submitted.

Disclosure(s):

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Carlo Di Mario, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)

Craig Thompson, MD, MMSc: kardion: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Teleflex: Consultant (Ongoing); Terumo Corporation: Consultant (Ongoing)